Global Surgical Hemostats Market Size, Share, and Forecast Analysis 2025-2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

What Are the Surgical Hemostats Market Size Forecast for 2025?
In recent times, there has been a robust expansion in the size of the surgical hemostats market. The market, which was valued at $3.68 billion in 2024, is expected to soar to $3.93 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This growth observed during the historic period is ascribed to an increase in the number of surgical procedures, a surge in cases of trauma and accidents, a growing proportion of the aged population, greater adoption of minimally invasive surgeries, and a rising occurrence of chronic diseases.

What Is the Market Size Outlook for Surgical Hemostats Until 2029?
The market for surgical hemostats is set to witness impressive expansion in the coming years, with the estimated market size poised to reach $5.09 billion by 2029, while growing at a compound annual growth rate (CAGR) of 6.6%. This projected growth over the forecast period can be attributed to several factors including increased demand for sophisticated solutions for wound closure, rising count of ambulatory surgical centers, an uptick in preference for biodegradable hemostats, expanding utilization of blended hemostatic agents and a surge in instances of lifestyle diseases calling for surgical intervention. Key trends shaping the market over the forecast period encompass advancements in absorbable hemostat technology, interoperation with robotic surgical procedures, development of next-generation hemostatic formulations, amalgamation with high-tech surgical devices, and plant-based hemostatic strategies gaining traction.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/surgical-hemostats-global-market-report

What Are the Major Factors Driving Demand in the Surgical Hemostats Market?
The anticipated surge in trauma cases is likely to drive the expansion of the surgical hemostats market. Trauma is a physical harm or emotional distress caused by a negative or harmful event that can physically or mentally impact an individual. The primary reason for the growth in trauma occurrences is the rise in road traffic accidents, which result in severe injuries needing immediate medical attention. Surgical hemostats play a crucial role in controlling bleeding efficiently and swiftly in trauma cases, aiding in minimizing blood loss and stabilizing patients for further care. For example, the Wisconsin Department of Health Services, a U.S. government agency, reported that in 2023, traumatic injuries due to assault increased by 3% from 2022, rising from 1,544 to 1,584 cases. Hence, the increasing incidences of trauma are propelling the surgical hemostats market's growth.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25916&type=smp

How Are End-Use Segments Shaping the Surgical Hemostats Market Outlook?
The surgical hemostats market covered in this report is segmented -

1) By Product Type: Topical Thrombin-Based Hemostats, Flowable Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Combination Hemostats, Other Product Types
2) By Formulation: Matrix And Gel Hemostats, Sponge Hemostats, Sheet And Pad Hemostats, Powder Hemostats
3) By Application: Neurological Surgery, Orthopedic Surgery, Cardiovascular Surgery, Gynecological Surgery, Trauma, Plastic Surgery, Other Applications
4) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:
1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats, Bovine Thrombin-Based Hemostats, Recombinant Thrombin-Based Hemostats, Formulations Gel, Spray, Powder, Sponge
2) By Flowable Hemostats: Gelatin Matrix With Thrombin, Collagen-Based Flowables, Synthetic Polymer-Based Flowables
3) By Collagen-Based Hemostats: Microfibrillar Collagen, Nonwoven Collagen Pads, Collagen Fleece Or Sheets
4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric, Non-woven Oxidized Regenerated Cellulose Pads, Oxidized Regenerated Cellulose With Additives
5) By Gelatin-Based Hemostats: Gelatin Sponge, Gelatin Powder, Gelatin Foam With Thrombin
6) By Combination Hemostats: Gelatin + Thrombin, Collagen + Thrombin, Oxidized Regenerated Cellulose + Thrombin
7) By Other Product Types: Chitosan-Based Hemostats, Kaolin-Based Hemostats, Synthetic Peptide Hemostats, Plant-Derived Agents

What Are the Strategic Trends Transforming the Surgical Hemostats Market Landscape?
Primary corporations in the surgical hemostat market are spearheading the development of innovative products through the use of absorbable oxidized regenerated cellulose (ORC), an inventive material. This approach is aimed at bettering bleeding control and accelerating the healing of wounds. Absorbable oxidized regenerated cellulose is a biodegradable material extracted from plants and plays a vital role in surgical hemostats. It achieves this by creating a physical barrier and fostering the formation of a clot at the wound site. For example, Futura Surgicare Pvt. Ltd., a medical device manufacturer in India, introduced Hemostax in February 2022. Hemostax is a sophisticated absorbable oxidized regenerated cellulose hemostat specially designed to manage intraoperative bleeding effectively. Hemostasis starts within 1.5 minutes of using this product, and its full impact is felt from 2 to 5 minutes. The product gets fully absorbed within 1 to 2 weeks without any requirement for removal. Utilization of the product is easy, it adapts to various surgical locations, presents no toxicity, is biocompatible, and effectively fights against bacteria resistant to drugs.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25916&type=smp

Who Are the Prominent Companies in the Surgical Hemostats Market by ?
Major companies operating in the surgical hemostats market are Johnson And Johnson Services Inc., Medtronic plc, Becton dic*kinson And Company, Stryker Corporation, Baxter International Inc., Teleflex Corporation, Integra LifeSciences Holdings Corporation., GELITA MEDICAL GmbH, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Axio Biosolutions Pvt. Ltd., Marine Polymer Technologies Inc, Biom'up USA Inc, Lotus Surgicals Pvt. Ltd, Hemostasis LLC, Biocer Entwicklungs-GmbH, CuraMedical BV, EndoClot Plus Inc, Starch Medical Inc, Tricol Biomedical Inc

Which Region Is Expected to See the Highest CAGR in the Surgical Hemostats Market?
North America was the largest region in the surgical hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.